Dr. Hana Al-Abdulkarim is currently the Director of Drug Policy and Economic Center DPEC in NGHA (Riyadh, KSA). She is also the President of the International Society for Pharmacoeconomics & Outcomes Research (ISPOR)-Saudi Arabia. Prior to this, she worked as Health economist specializing mainly in conducting pharmacoeconomic evaluations of Oncology/Hematolgy medications as a member in Corporate P&T committee and all P&T subcommittees.

She has Pharmacy degree from King Saud University in KSA (2008). In 2012, she completed Post-Graduate Diploma in Business and Law from University of Sheffield, UK. In 2014, she obtained her master degree on Health Economics and Decision Modeling from the University of Sheffield in UK in addition to training in Health Economics at the University of Manchester. In 2019, she completed the Health Economics and Outcomes Research Certificate program from The University of Washington, USA.

Dr. Hana’s main professional and research interest is health economics and outcomes research , optimal healthcare resource allocation , informing decision making with regard to Drug-use and finding cost-control strategies. She has been an invited speaker of local and international conferences. She participated as a main author or co-author in over 40 publications.